Study offers new insight on HIV transmission risk of men who have sex with men

August 7, 2008,

Approximately half of all new HIV infections in the United States result from the sexual risk behaviors of men who have sex with men. Now, a new study led by a researcher at The Miriam Hospital provides additional insight into which of these men are most likely to transmit HIV to others, potentially paving the way for the development of more targeted prevention programs.

Based on the study's findings, which were presented today, August 7, at the XVII International AIDS Conference (AIDS 2008) in Mexico City, researchers suggest that prevention programs for HIV-infected men who have sex with men focus on younger, more recently diagnosed men, as well as those who binge drink and use substances such as methamphetamine.

"Although the number of HIV diagnoses among men in this group decreased the last two decades, recent data shows these rates are on the rise again, making it critical that we continue to understand this group in order to guide prevention and education efforts," says lead author Kenneth H. Mayer, MD, an infectious disease physician at The Miriam Hospital and a professor of medicine at The Warren Alpert Medical School of Brown University.

Approximately 200 HIV-infected men who have sex with men participated in an HIV transmission risk reduction behavioral intervention. They completed a computer-administered psychosocial assessment that showed just about half of the men had a detectable amount of virus in their blood, known as an HIV viral load, and 57 percent were on highly active antiretroviral therapy (HAART), a combination of antiretroviral drugs aimed at treating HIV. Three-quarters of the men were Caucasian and more than half were college-educated.

Based on data analysis, researchers determined that about half of the participants in the study met the criteria for being a high-risk HIV transmitter. This was defined as engaging in unprotected insertive or receptive anal intercourse over the last six months with partners who are either HIV positive or of unknown status. It also includes men who have a detectable HIV viral load or have been diagnosed with a sexually transmitted infection (STI) within the past year.

Nearly a quarter of men surveyed said they consumed five or more alcoholic drinks daily at least once in the previous three months and 65 percent reported other substance use, including 30 percent who admitted to using methamphetamine. Within the past year, about 12 percent of men were diagnosed with an STI.

"When one drinks or uses other substances, inhibitions are lowered, making people more likely to engage in risky behavior, like unprotected sex. This is particularly true for young people, who often take risks without thinking about the consequences. Some patients who are newly diagnosed might be in denial, which could lead to poor decisions when it comes to sex," Mayer says. "Unfortunately, such behaviors put the partners of these men at great risk for contracting HIV and unknowingly transmitting it to others."

Source: Lifespan

Explore further: New evidence supports HIV screening in young adulthood

Related Stories

New evidence supports HIV screening in young adulthood

December 19, 2017
A new study suggests that the most beneficial age for a one-time screening HIV test of the general population would be age 25. The report - led by researchers at Massachusetts General Hospital (MGH) working with the U.S. ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

Primary care crucial for preventing new HIV infections

December 19, 2017
(HealthDay)—Primary care providers will play an important role in preventing the next wave of HIV infections, according to a report published in Medical Economics.

Introducing internet-based testing for STIs doubles testing uptake in South London boroughs

December 27, 2017
The randomised controlled trial of more than 2,000 people in Lambeth and Southwark was led by the London School of Hygiene & Tropical Medicine and King's College London, in partnership with SH:24, a digital sexual health ...

ADHD medications may reduce the risk of sexually transmitted infection

January 2, 2018
Attention-deficit/hyperactivity disorder (ADHD) increases the risk of subsequent sexually transmitted infections (STIs) among adolescent and young adult populations by about three times, reports a study published in the January ...

NIH launches HIV prevention trial of long-acting injectable medication in women

November 30, 2017
The first large-scale clinical trial of a long-acting injectable medication for HIV prevention in sexually active women has begun. The study in southern and eastern Africa will examine whether a long-acting form of the investigational ...

Recommended for you

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.

Could gene therapy someday eliminate HIV?

January 3, 2018
(HealthDay)—Gene therapy may have the potential to eradicate HIV in people infected with the virus, new animal research suggests.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.